Deakin University
Browse
- No file added yet -

Beta-lactam antibiotics as a possible novel therapy for managing epilepsy and autism, a case report and review of literature.

Download (279.67 kB)
Version 2 2024-06-17, 12:53
Version 1 2015-03-04, 12:02
journal contribution
posted on 2024-06-17, 12:53 authored by A Ghanizadeh, Michael BerkMichael Berk
Autism is a disorder of unknown etiology. There are few FDA approved medications for treating autism. Co-occurring autism and epilepsy is common, and glutamate antagonists improve some symptoms of autism. Ceftriaxone, a beta-lactam antibiotic, increases the expression of the glutamate transporter 1 which decreases extracellular glutamate levels. It is hypothesized that modulating astrocyte glutamate transporter expression by ceftriaxone or cefixime might improve some symptoms of autism. This case report of a child with autism and epilepsy suggests a decrease in seizures after taking cefixime.

History

Journal

Iranian Journal of Child Neurology

Volume

9

Pagination

99-102

Location

Iran

Open access

  • Yes

ISSN

2008-0700

eISSN

2008-0700

Language

eng

Publication classification

C3 Non-refereed articles in a professional journal

Copyright notice

2015, Iranian Child Neurology Society

Issue

1

Publisher

Iranian Child Neurology Society